Literature DB >> 23389995

Association of gray matter atrophy with age, β-amyloid, and cognition in aging.

Hwamee Oh1, Cindee Madison, Sylvia Villeneuve, Candace Markley, William J Jagust.   

Abstract

Both cognitive aging and β-amyloid (Aβ) deposition, a pathological hallmark of Alzheimer's disease, are associated with structural and cognitive changes in cognitively normal older people. To examine independent effects of age and Aβ deposition on cognition and brain structure in aging, 83 cognitively normal older adults underwent structural magnetic resonance imaging scans and neuropsychological tests and were classified as negative (PIB-) or positive (PIB+) for Aβ deposition using the radiotracer Pittsburgh compound B (PIB). Weighted composite discriminant scores represented subjects' cognition. Older adults showed age-related gray matter (GM) atrophy across the whole brain regardless of Aβ deposition. Amyloid burden within PIB+ subjects, however, was associated with GM atrophy in the frontal, parietal, and temporal cortices. Associations between cognition and volume in PIB- subjects were primarily seen throughout frontal regions and the striatum, while, in PIB+ subjects, these associations were seen in orbital-frontal and hippocampal regions. Furthermore, in PIB- subjects, cognition was related to putaminal volume, but not to hippocampus, while, in PIB+ subjects, cognition was related to hippocampal volume, but not to putamen. These findings highlight differential age and Aβ effects on brain structure, indicating effects of age and Aβ that operate somewhat independently to affect frontostriatal and medial temporal brain systems.

Entities:  

Keywords:  Pittsburgh compound B-positron emission tomography; aging; amyloid; cognition; structure

Mesh:

Substances:

Year:  2013        PMID: 23389995      PMCID: PMC4014182          DOI: 10.1093/cercor/bht017

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  45 in total

1.  Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects.

Authors:  E C Mormino; J T Kluth; C M Madison; G D Rabinovici; S L Baker; B L Miller; R A Koeppe; C A Mathis; M W Weiner; W J Jagust
Journal:  Brain       Date:  2008-11-28       Impact factor: 13.501

2.  Selective increase of cortical thickness in high-performing elderly--structural indices of optimal cognitive aging.

Authors:  Anders M Fjell; Kristine B Walhovd; Ivar Reinvang; Arvid Lundervold; David Salat; Brian T Quinn; Bruce Fischl; Anders M Dale
Journal:  Neuroimage       Date:  2005-09-19       Impact factor: 6.556

3.  Extrahippocampal contributions to age differences in human spatial navigation.

Authors:  Scott D Moffat; Kristen M Kennedy; Karen M Rodrigue; Naftali Raz
Journal:  Cereb Cortex       Date:  2006-07-20       Impact factor: 5.357

4.  PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment.

Authors:  N M Kemppainen; S Aalto; I A Wilson; K Någren; S Helin; A Brück; V Oikonen; M Kailajärvi; M Scheinin; M Viitanen; R Parkkola; J O Rinne
Journal:  Neurology       Date:  2007-05-08       Impact factor: 9.910

5.  Selective changes of resting-state networks in individuals at risk for Alzheimer's disease.

Authors:  Christian Sorg; Valentin Riedl; Mark Mühlau; Vince D Calhoun; Tom Eichele; Leonhard Läer; Alexander Drzezga; Hans Förstl; Alexander Kurz; Claus Zimmer; Afra M Wohlschläger
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-14       Impact factor: 11.205

6.  11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment.

Authors:  Clifford R Jack; Val J Lowe; Matthew L Senjem; Stephen D Weigand; Bradley J Kemp; Maria M Shiung; David S Knopman; Bradley F Boeve; William E Klunk; Chester A Mathis; Ronald C Petersen
Journal:  Brain       Date:  2008-02-07       Impact factor: 13.501

7.  Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia.

Authors:  Federica Agosta; Keith A Vossel; Bruce L Miller; Raffaella Migliaccio; Stephen J Bonasera; Massimo Filippi; Adam L Boxer; Anna Karydas; Katherine L Possin; Maria Luisa Gorno-Tempini
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-22       Impact factor: 11.205

8.  Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents.

Authors:  Chester A Mathis; Yanming Wang; Daniel P Holt; Guo-Feng Huang; Manik L Debnath; William E Klunk
Journal:  J Med Chem       Date:  2003-06-19       Impact factor: 7.446

9.  The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals.

Authors:  Bradford C Dickerson; Akram Bakkour; David H Salat; Eric Feczko; Jenni Pacheco; Douglas N Greve; Fran Grodstein; Christopher I Wright; Deborah Blacker; H Diana Rosas; Reisa A Sperling; Alireza Atri; John H Growdon; Bradley T Hyman; John C Morris; Bruce Fischl; Randy L Buckner
Journal:  Cereb Cortex       Date:  2008-07-16       Impact factor: 5.357

10.  Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease.

Authors:  Clifford R Jack; Val J Lowe; Stephen D Weigand; Heather J Wiste; Matthew L Senjem; David S Knopman; Maria M Shiung; Jeffrey L Gunter; Bradley F Boeve; Bradley J Kemp; Michael Weiner; Ronald C Petersen
Journal:  Brain       Date:  2009-03-31       Impact factor: 13.501

View more
  31 in total

1.  White matter tract covariance patterns predict age-declining cognitive abilities.

Authors:  Yunglin Gazes; F DuBois Bowman; Qolamreza R Razlighi; Deirdre O'Shea; Yaakov Stern; Christian Habeck
Journal:  Neuroimage       Date:  2015-10-19       Impact factor: 6.556

2.  Temporal Order of Alzheimer's Disease-Related Cognitive Marker Changes in BLSA and WRAP Longitudinal Studies.

Authors:  Murat Bilgel; Rebecca L Koscik; Yang An; Jerry L Prince; Susan M Resnick; Sterling C Johnson; Bruno M Jedynak
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

3.  Total Brain and Hippocampal Volumes and Cognition in Older American Indians: The Strong Heart Study.

Authors:  Brenna Cholerton; Adam Omidpanah; Tara M Madhyastha; Thomas J Grabowski; Astrid M Suchy-Dicey; Dean K Shibata; Lonnie A Nelson; Steven P Verney; Barbara V Howard; William T Longstreth; Thomas J Montine; Dedra Buchwald
Journal:  Alzheimer Dis Assoc Disord       Date:  2017 Apr-Jun       Impact factor: 2.703

Review 4.  Neurobiological Mechanisms of Stress Resilience and Implications for the Aged Population.

Authors:  Charlene Faye; Josephine C Mcgowan; Christine A Denny; Denis J David
Journal:  Curr Neuropharmacol       Date:  2018-03-05       Impact factor: 7.363

5.  Multiple pathways of reserve simultaneously present in cognitively normal older adults.

Authors:  Hwamee Oh; Qolamreza R Razlighi; Yaakov Stern
Journal:  Neurology       Date:  2017-12-22       Impact factor: 9.910

6.  The role of age on tau PET uptake and gray matter atrophy in atypical Alzheimer's disease.

Authors:  Jennifer L Whitwell; Peter Martin; Jonathan Graff-Radford; Mary M Machulda; Matthew L Senjem; Christopher G Schwarz; Stephen D Weigand; Anthony J Spychalla; Daniel A Drubach; Clifford R Jack; Val J Lowe; Keith A Josephs
Journal:  Alzheimers Dement       Date:  2019-03-08       Impact factor: 21.566

7.  Aβ-related hyperactivation in frontoparietal control regions in cognitively normal elderly.

Authors:  Hwamee Oh; Jason Steffener; Qolamreza R Razlighi; Christian Habeck; Dan Liu; Yunglin Gazes; Sarah Janicki; Yaakov Stern
Journal:  Neurobiol Aging       Date:  2015-08-24       Impact factor: 4.673

8.  Effects of cerebrospinal fluid proteins on brain atrophy rates in cognitively healthy older adults.

Authors:  Niklas Mattsson; Philip Insel; Rachel Nosheny; John Q Trojanowski; Leslie M Shaw; Clifford R Jack; Duygu Tosun; Michael Weiner
Journal:  Neurobiol Aging       Date:  2013-10-01       Impact factor: 4.673

9.  Evolution of neurodegeneration-imaging biomarkers from clinically normal to dementia in the Alzheimer disease spectrum.

Authors:  David S Knopman; Clifford R Jack; Emily S Lundt; Stephen D Weigand; Prashanthi Vemuri; Val J Lowe; Kejal Kantarci; Jeffrey L Gunter; Matthew L Senjem; Michelle M Mielke; Mary M Machulda; Rosebud O Roberts; Bradley F Boeve; David T Jones; Ronald C Petersen
Journal:  Neurobiol Aging       Date:  2016-06-16       Impact factor: 4.673

Review 10.  What is normal in normal aging? Effects of aging, amyloid and Alzheimer's disease on the cerebral cortex and the hippocampus.

Authors:  Anders M Fjell; Linda McEvoy; Dominic Holland; Anders M Dale; Kristine B Walhovd
Journal:  Prog Neurobiol       Date:  2014-02-16       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.